Myocardial Titin Hypophosphorylation Importantly Contributes to Heart Failure With Preserved Ejection Fraction in a Rat Metabolic Risk Model
暂无分享,去创建一个
W. Paulus | W. Linke | C. Ottenheijm | C. Tschöpe | A. Leite-Moreira | Arantxa González | I. Falcão-Pires | A. Lourenço | B. Lopez | J. Díez | D. Fontoura | P. Becher | N. Hamdani | S. Leite | C. Franssen | Luisa Plettig | J. Dı́ez | B. López
[1] W. Linke,et al. Differential changes in titin domain phosphorylation increase myofilament stiffness in failing human hearts. , 2013, Cardiovascular research.
[2] W. Linke,et al. Deranged myofilament phosphorylation and function in experimental heart failure with preserved ejection fraction. , 2013, Cardiovascular research.
[3] W. Linke,et al. Crucial Role for Ca2+/Calmodulin-Dependent Protein Kinase-II in Regulating Diastolic Stress of Normal and Failing Hearts via Titin Phosphorylation , 2013, Circulation research.
[4] R. Brook,et al. Low-Sodium Dietary Approaches to Stop Hypertension Diet Reduces Blood Pressure, Arterial Stiffness, and Oxidative Stress in Hypertensive Heart Failure With Preserved Ejection Fraction , 2012, Hypertension.
[5] J. Bronzwaer,et al. Low Myocardial Protein Kinase G Activity in Heart Failure With Preserved Ejection Fraction , 2012, Circulation.
[6] A. McCulloch,et al. A Novel Mechanism Involving Four-and-a-half LIM Domain Protein-1 and Extracellular Signal-regulated Kinase-2 Regulates Titin Phosphorylation and Mechanics* , 2012, The Journal of Biological Chemistry.
[7] F. Fedele,et al. Chronic Inhibition of cGMP Phosphodiesterase 5A Improves Diabetic Cardiomyopathy: A Randomized, Controlled Clinical Trial Using Magnetic Resonance Imaging With Myocardial Tagging , 2012, Circulation.
[8] Sameer Ather,et al. Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction. , 2012, Journal of the American College of Cardiology.
[9] R. Nishimura,et al. Effects of vasodilation in heart failure with preserved or reduced ejection fraction implications of distinct pathophysiologies on response to therapy. , 2012, Journal of the American College of Cardiology.
[10] W. Linke,et al. Sildenafil and B-Type Natriuretic Peptide Acutely Phosphorylate Titin and Improve Diastolic Distensibility In Vivo , 2011, Circulation.
[11] R. McKelvie,et al. Prevalence and Significance of Alterations in Cardiac Structure and Function in Patients With Heart Failure and a Preserved Ejection Fraction , 2011, Circulation.
[12] W. Paulus,et al. Diabetes Mellitus Worsens Diastolic Left Ventricular Dysfunction in Aortic Stenosis Through Altered Myocardial Structure and Cardiomyocyte Stiffness , 2011, Circulation.
[13] B. Massie,et al. Body Mass Index and Adverse Cardiovascular Outcomes in Heart Failure Patients With Preserved Ejection Fraction: Results From the Irbesartan in Heart Failure With Preserved Ejection Fraction (I-PRESERVE) Trial , 2011, Circulation. Heart failure.
[14] Frank Edelmann,et al. Contribution of comorbidities to functional impairment is higher in heart failure with preserved than with reduced ejection fraction , 2011, Clinical Research in Cardiology.
[15] W. Paulus,et al. Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment. , 2011, European heart journal.
[16] H. Brunner-La Rocca,et al. Hemodynamic basis of exercise limitation in patients with heart failure and normal ejection fraction. , 2010, Journal of the American College of Cardiology.
[17] W. Paulus. Culprit Mechanism(s) for Exercise Intolerance in Heart Failure With Normal Ejection Fraction. , 2010, Journal of the American College of Cardiology.
[18] Amir Lerman,et al. Global cardiovascular reserve dysfunction in heart failure with preserved ejection fraction. , 2010, Journal of the American College of Cardiology.
[19] M. LeWinter,et al. Cardiac titin: a multifunctional giant. , 2010, Circulation.
[20] W. Paulus,et al. Treatment of heart failure with normal ejection fraction: an inconvenient truth! , 2010, Journal of the American College of Cardiology.
[21] J. Oh,et al. Doppler echocardiography: a contemporary review. , 2009, Journal of cardiology.
[22] Siegfried Labeit,et al. PKC Phosphorylation of Titin’s PEVK Element: A Novel and Conserved Pathway for Modulating Myocardial Stiffness , 2009, Circulation research.
[23] W. Linke,et al. Titin-based mechanical signalling in normal and failing myocardium. , 2009, Journal of molecular and cellular cardiology.
[24] J. Bronzwaer,et al. Hypophosphorylation of the Stiff N2B Titin Isoform Raises Cardiomyocyte Resting Tension in Failing Human Myocardium , 2009, Circulation research.
[25] C. Tschöpe,et al. Enhancement of the endothelial NO synthase attenuates experimental diastolic heart failure , 2009, Basic Research in Cardiology.
[26] Christian Andresen,et al. Protein kinase G modulates human myocardial passive stiffness by phosphorylation of the titin springs , 2008, Circulation research.
[27] R. McKelvie,et al. Heart failure with preserved ejection fraction: Clinical characteristics of 4133 patients enrolled in the I‐PRESERVE trial , 2008, European journal of heart failure.
[28] K. Dickstein,et al. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. , 2007, European heart journal.
[29] Wolfgang A. Linke,et al. Protein kinase-A phosphorylates titin in human heart muscle and reduces myofibrillar passive tension , 2006, Journal of Muscle Research & Cell Motility.
[30] Mark C Leake,et al. Mechanical properties of cardiac titin's N2B-region by single-molecule atomic force spectroscopy. , 2006, Journal of structural biology.
[31] Wolfgang A Linke,et al. Myocardial Structure and Function Differ in Systolic and Diastolic Heart Failure , 2006, Circulation.
[32] G. Aurigemma,et al. Left Ventricular Systolic Performance, Function, and Contractility in Patients With Diastolic Heart Failure , 2005, Circulation.
[33] Yiming Wu,et al. Phosphorylation of Titin Modulates Passive Stiffness of Cardiac Muscle in a Titin Isoform-dependent Manner , 2005, The Journal of general physiology.
[34] Arantxa González,et al. Increased Collagen Type I Synthesis in Patients With Heart Failure of Hypertensive Origin: Relation to Myocardial Fibrosis , 2004, Circulation.
[35] H. Granzier,et al. Protein Kinase A Phosphorylates Titin’s Cardiac-Specific N2B Domain and Reduces Passive Tension in Rat Cardiac Myocytes , 2002, Circulation research.
[36] S. Bastacky,et al. RENAL FUNCTION AND STRUCTURE IN DIABETIC, HYPERTENSIVE, OBESE ZDFxSHHF-HYBRID RATS , 2000, Renal failure.
[37] T. Irving,et al. Passive tension in cardiac muscle: contribution of collagen, titin, microtubules, and intermediate filaments. , 1995, Biophysical journal.
[38] M. Roberts,et al. Diastolic abnormalities in young asymptomatic diabetic patients assessed by pulsed Doppler echocardiography. , 1988, Journal of the American College of Cardiology.
[39] J. Bronzwaer,et al. Diastolic Stiffness of the Failing Diabetic Heart: Importance of Fibrosis, Advanced Glycation End Products, and Myocyte Resting Tension , 2008, Circulation.
[40] P. Mozdziak,et al. Species variations in cDNA sequence and exon splicing patterns in the extensible I-band region of cardiac titin: relation to passive tension , 2004, Journal of Muscle Research & Cell Motility.
[41] Culprit Mechanism(s) for Exercise Intolerance in Heart Failure With Normal Ejection Fraction* , 2022 .